Novo Nordisk A/S in Constructive Dialogue with FDA on Victoza

COPENHAGEN, April 24 (Reuters) - Denmark's Novo Nordisk (NOVOb.CO)(NVO.N) said on Friday it was in constructive dialogue with U.S. agencies on its key new diabetes drug, Victoza, a day after European regulators recommended its approval.